The TNF-α protein level (Fig. 7G and H) was elevated by 3.18- and 8.75-fold in the glioma TME after treatment with SR717@RGE-HFn NPs compared to the free SR717 or PBS groups, respectively. The gene discussed is TNF; the disease is central nervous system cancer.